New breakthrough bee vaccine technology could help combat colony declines

Beekeepers across the U.S. got a nasty surprise this year. Millions of pollinating bees were dead, with reports coming in across the country. Now, one company specializing in honeybee health says it might have a solution to the problem.

Georgia-based Dalan Animal Health says recent colony losses have created big challenges for keepers and farmers, which is why they have developed a vaccine. It exposes quee bees to inactive diseases, allowing them to give immunity to the rest of the hive. Developers have been testing the vaccine since 2022 in over 200 hives.

New numbers show commercial beekeepers lost around 62 percent of the nation’s pollinating supply over the winter. Keepers at Project APIS-M found several issues are causing the drop, including parasites and a lack of food. Honeybees help fertilize 75 percent of the world’s supplies.

Related Stories
Farmdoc economist estimates 2024 colony stock losses at roughly $175 million, with rebuilding and renovation costs near $161 million.
New treatments offer hope, but challenges remain for beekeepers.
Transporting pollinator colonies—primarily honey bee hives—is a major logistical operation in U.S. agriculture. Costs can vary widely depending on distance, fuel prices, labor, and timing.
Georgia Ag Commissioner Tyler Harper explains the growing threat of invasive hornets in his state and what Southeastern growers should watch for this spring.
Smaller beekeepers may find opportunities despite ongoing colony health challenges.
Lower production is tightening honey supplies across markets.

LATEST STORIES BY THIS AUTHOR:

The Farm Bureau’s honor highlights the important role farm dogs play on operations across the country, serving as dependable workers and trusted companions.
Logistics capacity remains available, but winter volatility favors flexible delivery and marketing plans. NGFA President Mike Seyfert provides insight into grain transportation trends, trade policy, and priorities for the year ahead.
Rising adoption of GLP-1 drugs may gradually reshape food demand, with potential downstream effects on protein markets and consumer purchasing patterns.
Traders are keeping a close eye on China’s soybean purchases as markets track export sales, shipments, and progress toward the ‘magical’ 12 million ton target promised last year.
Leadership development and bipartisan engagement remain central to advancing agriculture’s priorities in 2026.
AFBF Economist Faith Parum provides analysis and perspective on the Farmer Bridge Assistance Program—what commodity growers should know and potential remedies for producers facing crop losses where that aid falls short.